[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancers Immunotherapy Drugs Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: CE7521E680DAEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cancers Immunotherapy Drugs in Global, including the following market information:

Global Cancers Immunotherapy Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cancers Immunotherapy Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancers Immunotherapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancers Immunotherapy Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cancers Immunotherapy Drugs Market Segment Percentages, By Type, 2020 (%)
  • Monoclonal Antibodies
  • Check Point Inhibitors
  • Interferons
  • Interleukins
China Cancers Immunotherapy Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cancers Immunotherapy Drugs Market Segment Percentages, By Application, 2020 (%)
  • Lung Cancer
  • Liver Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Other Cancers
Global Cancers Immunotherapy Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cancers Immunotherapy Drugs Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cancers Immunotherapy Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cancers Immunotherapy Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Roche
  • Pfizer
  • Merck
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • GlaxoSmithKline
  • Amgen
  • AbbVie
  • Boehringer Ingelheim
  • AstraZeneca
  • Immatics Biotechnologies
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancers Immunotherapy Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancers Immunotherapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCERS IMMUNOTHERAPY DRUGS OVERALL MARKET SIZE

2.1 Global Cancers Immunotherapy Drugs Market Size: 2021 VS 2027
2.2 Global Cancers Immunotherapy Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancers Immunotherapy Drugs Players in Global Market
3.2 Top Global Cancers Immunotherapy Drugs Companies Ranked by Revenue
3.3 Global Cancers Immunotherapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cancers Immunotherapy Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancers Immunotherapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancers Immunotherapy Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Cancers Immunotherapy Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancers Immunotherapy Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cancers Immunotherapy Drugs Market Size Markets, 2021 & 2027
  4.1.2 Monoclonal Antibodies
  4.1.3 Check Point Inhibitors
  4.1.4 Interferons
  4.1.5 Interleukins
4.2 By Type - Global Cancers Immunotherapy Drugs Revenue & Forecasts
  4.2.1 By Type - Global Cancers Immunotherapy Drugs Revenue, 2016-2021
  4.2.2 By Type - Global Cancers Immunotherapy Drugs Revenue, 2022-2027
  4.2.3 By Type - Global Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancers Immunotherapy Drugs Market Size, 2021 & 2027
  5.1.2 Lung Cancer
  5.1.3 Liver Cancer
  5.1.4 Colorectal Cancer
  5.1.5 Pancreatic Cancer
  5.1.6 Breast Cancer
  5.1.7 Other Cancers
5.2 By Application - Global Cancers Immunotherapy Drugs Revenue & Forecasts
  5.2.1 By Application - Global Cancers Immunotherapy Drugs Revenue, 2016-2021
  5.2.2 By Application - Global Cancers Immunotherapy Drugs Revenue, 2022-2027
  5.2.3 By Application - Global Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cancers Immunotherapy Drugs Market Size, 2021 & 2027
6.2 By Region - Global Cancers Immunotherapy Drugs Revenue & Forecasts
  6.2.1 By Region - Global Cancers Immunotherapy Drugs Revenue, 2016-2021
  6.2.2 By Region - Global Cancers Immunotherapy Drugs Revenue, 2022-2027
  6.2.3 By Region - Global Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cancers Immunotherapy Drugs Revenue, 2016-2027
  6.3.2 US Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.3.3 Canada Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.3.4 Mexico Cancers Immunotherapy Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cancers Immunotherapy Drugs Revenue, 2016-2027
  6.4.2 Germany Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.4.3 France Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.4.4 U.K. Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.4.5 Italy Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.4.6 Russia Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.4.8 Benelux Cancers Immunotherapy Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cancers Immunotherapy Drugs Revenue, 2016-2027
  6.5.2 China Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.5.3 Japan Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.5.4 South Korea Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.5.6 India Cancers Immunotherapy Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cancers Immunotherapy Drugs Revenue, 2016-2027
  6.6.2 Brazil Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.6.3 Argentina Cancers Immunotherapy Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue, 2016-2027
  6.7.2 Turkey Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.7.3 Israel Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia Cancers Immunotherapy Drugs Market Size, 2016-2027
  6.7.5 UAE Cancers Immunotherapy Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Cancers Immunotherapy Drugs Major Product Offerings
  7.1.4 Roche Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Cancers Immunotherapy Drugs Major Product Offerings
  7.2.4 Pfizer Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.2.5 Pfizer Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Cancers Immunotherapy Drugs Major Product Offerings
  7.3.4 Merck Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.3.5 Merck Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Cancers Immunotherapy Drugs Major Product Offerings
  7.4.4 Novartis Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.4.5 Novartis Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Cancers Immunotherapy Drugs Major Product Offerings
  7.5.4 Johnson & Johnson Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.5.5 Johnson & Johnson Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Cancers Immunotherapy Drugs Major Product Offerings
  7.6.4 Sanofi Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.6.5 Sanofi Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Cancers Immunotherapy Drugs Major Product Offerings
  7.4.4 GlaxoSmithKline Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.7.5 GlaxoSmithKline Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen Cancers Immunotherapy Drugs Major Product Offerings
  7.8.4 Amgen Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.8.5 Amgen Key News
7.9 AbbVie
  7.9.1 AbbVie Corporate Summary
  7.9.2 AbbVie Business Overview
  7.9.3 AbbVie Cancers Immunotherapy Drugs Major Product Offerings
  7.9.4 AbbVie Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.9.5 AbbVie Key News
7.10 Boehringer Ingelheim
  7.10.1 Boehringer Ingelheim Corporate Summary
  7.10.2 Boehringer Ingelheim Business Overview
  7.10.3 Boehringer Ingelheim Cancers Immunotherapy Drugs Major Product Offerings
  7.10.4 Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.10.5 Boehringer Ingelheim Key News
7.11 AstraZeneca
  7.11.1 AstraZeneca Corporate Summary
  7.11.2 AstraZeneca Business Overview
  7.11.3 AstraZeneca Cancers Immunotherapy Drugs Major Product Offerings
  7.11.4 AstraZeneca Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.11.5 AstraZeneca Key News
7.12 Immatics Biotechnologies
  7.12.1 Immatics Biotechnologies Corporate Summary
  7.12.2 Immatics Biotechnologies Business Overview
  7.12.3 Immatics Biotechnologies Cancers Immunotherapy Drugs Major Product Offerings
  7.12.4 Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue in Global (2016-2021)
  7.12.5 Immatics Biotechnologies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Cancers Immunotherapy Drugs Market Opportunities & Trends in Global Market
Table 2. Cancers Immunotherapy Drugs Market Drivers in Global Market
Table 3. Cancers Immunotherapy Drugs Market Restraints in Global Market
Table 4. Key Players of Cancers Immunotherapy Drugs in Global Market
Table 5. Top Cancers Immunotherapy Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancers Immunotherapy Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancers Immunotherapy Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancers Immunotherapy Drugs Product Type
Table 9. List of Global Tier 1 Cancers Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancers Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancers Immunotherapy Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancers Immunotherapy Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Cancers Immunotherapy Drugs Product Offerings
Table 32. Roche Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Cancers Immunotherapy Drugs Product Offerings
Table 35. Pfizer Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Merck Corporate Summary
Table 37. Merck Cancers Immunotherapy Drugs Product Offerings
Table 38. Merck Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Novartis Corporate Summary
Table 40. Novartis Cancers Immunotherapy Drugs Product Offerings
Table 41. Novartis Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Cancers Immunotherapy Drugs Product Offerings
Table 44. Johnson & Johnson Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Cancers Immunotherapy Drugs Product Offerings
Table 47. Sanofi Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Cancers Immunotherapy Drugs Product Offerings
Table 50. GlaxoSmithKline Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Amgen Corporate Summary
Table 52. Amgen Cancers Immunotherapy Drugs Product Offerings
Table 53. Amgen Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 54. AbbVie Corporate Summary
Table 55. AbbVie Cancers Immunotherapy Drugs Product Offerings
Table 56. AbbVie Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Boehringer Ingelheim Corporate Summary
Table 58. Boehringer Ingelheim Cancers Immunotherapy Drugs Product Offerings
Table 59. Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 60. AstraZeneca Corporate Summary
Table 61. AstraZeneca Cancers Immunotherapy Drugs Product Offerings
Table 62. AstraZeneca Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)
Table 63. Immatics Biotechnologies Corporate Summary
Table 64. Immatics Biotechnologies Cancers Immunotherapy Drugs Product Offerings
Table 65. Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Cancers Immunotherapy Drugs Segment by Type
Figure 2. Cancers Immunotherapy Drugs Segment by Application
Figure 3. Global Cancers Immunotherapy Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancers Immunotherapy Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancers Immunotherapy Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancers Immunotherapy Drugs Revenue in 2020
Figure 8. By Type - Global Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 12. US Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 24. China Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merck Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Novartis Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Johnson & Johnson Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Sanofi Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. GlaxoSmithKline Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Amgen Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. AbbVie Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. AstraZeneca Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications